Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2008 / Cilt: 9 - Sayı: 2

Correlation between serum IL-8 levels and disease activity in patients with ankylosing spondylitis

Ankilozan spondilit hastalarında serum IL-8 düzeyi ve hastalık aktivitesi ile ilişkisi

Pages
21–24
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finding a significant relationship between serum IL-8 level and these two parameters may indicate that serum IL-8 level could be used as an objective marker tomonitor the disease activityin AS patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the axial skeleton, affecting mainly the sacroiliac joints and the lumbar spine.
📊
Key Findings & Data:The aims of this study were to determine serum interleukin-8 (IL-8) levels inAS patients and also to determine the relationship between these levels and disease activity Materials and Methods: Twenty-eight patients with a diagnosis of AS according to the modified New York criteria were included in this study.
💡
Conclusion & Impact:Finding a significant relationship between serum IL-8 level and these two parameters may indicate that serum IL-8 level could be used as an objective marker tomonitor the disease activityin AS patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Ankylosing Spondylitis (AS) is a chronic inflammatory disorder of the axial skeleton, affecting mainly the sacroiliac joints and the lumbar spine. Cytokines are believed to be responsible for the pathogenesis of the disease. The aims of this study were to determine serum interleukin-8 (IL-8) levels inAS patients and also to determine the relationship between these levels and disease activity Materials and Methods: Twenty-eight patients with a diagnosis of AS according to the modified New York criteria were included in this study. BASDAI, BASFI, BASMI and Maastricht Ankylosing Spondylitis Enthesis Score (MASES) indexes were used for clinical evaluation of the patients. Serum IL-8 levels were measured by ELISA.Results: The mean age and disease duration of the patients were 35.4(10.8) years and 75(97.1) months respectively. The mean serum IL-8 level was 67.3(22.9) pg/mL. Among the evaluated clinical and laboratuary parameters a significant correlation was observed only between serum IL-8 levels and CRP (p=0,048) and also BASDAI (P=0,005).Conclusion: BASDAI and CRPare two important clinical parameters which are used inthe evaluationofdisease activity inAS patients. Finding a significant relationship between serum IL-8 level and these two parameters may indicate that serum IL-8 level could be used as an objective marker tomonitor the disease activityin AS patients.

Özet

Amaç: Ankilozan spondilit (AS) başlıca sakroiliak eklem ve lomber omurga olmak üzere aksiyel iskelet tutulumu ile giden kronik inflamatuar bir hastalıktır. Hastalığın patogenezinden sitokinlerin sorumlu olabileceği düşünülmektedir. Bu çalışmanın amaçlarını AS'li hastalarda serum IL-8 düzeylerinin belirlenmesi ve IL-8 düzeyleri ile hastalık aktivitesi arasındaki ilişkinin saptanması oluşturmaktadır. Gereç ve Yöntem: Modifiye New York kriterlerine göre AS tanısı almış 28 hasta çalışmaya dahil edildi. Hastaların klinik değerlendirilmelerinde BASDAI, BASFİ, BASMİ ve Maastricht Ankylosing Spondylitis Enthesis Score (MASES) indeksleri kullanıldı. ELISA yöntemi ile serum IL-8 düzeyleri ölçüldü.Bulgular: Hastaların ortalama yaş ve hastalık süreleri sırasıyla 35,4±10,8 yıl ve 75±97,1 ay olarak saptandı. Serum IL-8 düzeyleri ortalama 67,3±22,9 pg/mL olarak ölçüldü. Serum IL-8 düzeyinin diğer klinik ve laboratuar parametreler ile karşılaştırılmasında, sadece C-reaktif protein düzeyi (P=0,048) ve BASDAI (P=0,005) ile anlamlı ilişki gösterdiği gözlendi.Sonuç: BASDAI ve CRP AS'li hastaların klinik aktivitelerini değerlendirmede kullanılan iki önemli parametredir. Bu çalışmada saptanan serum IL-8 ile BASDAI ve CRP arasındaki ilişki serum IL-8 düzeylerinin hastalık aktivitesinin takibinde kullanılabilecek objektif bir belirteç olduğunu gösterebilir.

🔖

Cite This Article

GÜRGAN, A., KARAYAĞIZ, S., TURAN, Y., BAL, S. (2022). Correlation between serum IL-8 levels and disease activity in patients with ankylosing spondylitis. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 9 - Sayı: 2, 21–24. https://ajindex.com/articles/429013

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Van der Linden S, Van der Heijde D, Braun J. Spondyloarthropathies: Ankylosing spondylitis. Kelley's textbook of rheumatology, seventh edition, Harris ED(ed), Elsevier, Philadelphia, 2005:1125-42
  2. Bal A, Unlu E, Bahar G, Aydog E, Eksioglu E, Yorgancioglu R. Comparison of serum IL-1ß, Sil-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 2007; 26: 211-5
  3. Gratacos J, Filella X, Sanmarti R, Canete J, Llena J, MolinaR, etal. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol 1994; 33(10): 927-31
  4. Sonel B, Tutkak H, Düzgün N. Serum levels of IL-1 beta, TNF-alpha, IL-8, and acute phase proteins in seronegative spondyloarthropathies. Joint Bone Spine 2002; 69: 463-7
  5. Toussirot E, Lafforgue P, Boucraut J, Despieds P, Schina A, Bernard D, et al. Serum levels of interleukin 1-beta, tumor necrosis factor-alpha, soluble interleukin 2 recetor and soluble CD8 in seronegative spondyloarthropathies. Rheumatol Int 1994; 13(5): 175-80
  6. Kumar V. Basic pathology. 5th edition: W.B. Saunders, Philadelphia, 1995: 25-40
  7. Roitt I, Brosstoff J, Male D. Immunology. Fourth edition: Mosby,London:1998
  8. Lin E, Calvono E, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000; 127(2):117-26
  9. Rot A. Endothelial cell binding of NAPI/IL-8: Role in neutrophil migration. Immunol Today 1992; 51: 236-65
  10. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for the modification of the New York criteria. ArthritisRheum1984;27: 3618
  11. Garrett SL, Jenkinson TR, Kennedy LG, Kennedy LG, Whitelock HC, Gaisford P, et al. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 1994; 21:2286-91
  12. Akkoç Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 2005; 25(4):280-4
  13. Calin A, Garrett SL, Whitelock HC, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index (BASFI). J Rheumatol 1994; 21:2281-5
  14. Yanik B, Gursel YK, Kutlay S, Ay S, Elhan AH. Adaptation of the Bath Ankylosing Spondylitis Funct